199 related articles for article (PubMed ID: 30201519)
1. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.
Ju Y; Janga SR; Klinngam W; MacKay JA; Hawley D; Zoukhri D; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2018 Nov; 176():243-251. PubMed ID: 30201519
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.
Li X; Wu K; Edman M; Schenke-Layland K; MacVeigh-Aloni M; Janga SR; Schulz B; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5019-29. PubMed ID: 20463324
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
[TBL] [Abstract][Full Text] [Related]
4. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
[TBL] [Abstract][Full Text] [Related]
5. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.
Fu R; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562815
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
8. Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development.
da Costa SR; Wu K; Veigh MM; Pidgeon M; Ding C; Schechter JE; Hamm-Alvarez SF
Exp Eye Res; 2006 Jan; 82(1):33-45. PubMed ID: 16005870
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition.
Doyle ME; Boggs L; Attia R; Cooper LR; Saban DR; Nguyen CQ; Peck AB
Am J Pathol; 2007 Oct; 171(4):1224-36. PubMed ID: 17823290
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy.
Schenke-Layland K; Xie J; Magnusson M; Angelis E; Li X; Wu K; Reinhardt DP; Maclellan WR; Hamm-Alvarez SF
Exp Eye Res; 2010 Feb; 90(2):223-37. PubMed ID: 19852957
[TBL] [Abstract][Full Text] [Related]
13. Leakage of aquaporin 5 in the tear of dacryoadenitis mice.
Hirai S; Ishida N; Watanabe K; Mita S
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2432-7. PubMed ID: 10937550
[TBL] [Abstract][Full Text] [Related]
14. High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid.
Takahashi M; Ishimaru N; Yanagi K; Haneji N; Saito I; Hayashi Y
Clin Exp Immunol; 1997 Sep; 109(3):555-61. PubMed ID: 9328136
[TBL] [Abstract][Full Text] [Related]
15. BXSB/MpJ-Yaa mice develop autoimmune dacryoadenitis with the appearance of inflammatory cell marker messenger RNAs in the lacrimal fluid.
Kosenda K; Ichii O; Otsuka S; Hashimoto Y; Kon Y
Clin Exp Ophthalmol; 2013 Nov; 41(8):788-97. PubMed ID: 23433092
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.
Wu K; Joffre C; Li X; MacVeigh-Aloni M; Hom M; Hwang J; Ding C; Gregoire S; Bretillon L; Zhong JF; Hamm-Alvarez SF
Exp Eye Res; 2009 Sep; 89(3):319-32. PubMed ID: 19345210
[TBL] [Abstract][Full Text] [Related]
17. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Lieberman SM; Kreiger PA; Koretzky GA
Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706
[TBL] [Abstract][Full Text] [Related]
18. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.
Zhou J; Jin JO; Du J; Yu Q
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7831-8. PubMed ID: 26658504
[TBL] [Abstract][Full Text] [Related]
19. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
[TBL] [Abstract][Full Text] [Related]
20. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
